Eton Pharmaceuticals, Inc.

ETONNasdaqCIK: 0001710340

Eton Pharmaceuticals, Inc. (ETON) shows 34 recent insider filings from 11 insiders, with all of them on the sell side. With $0 in purchases and $16.2M in sales, the recent tape is heavily weighted toward selling (net sales of $16.2M). BRYNJELSEN SEAN (President & CEO, Director) is the most active by dollar volume, and the single largest transaction was $4.8M by Opaleye Management Inc.. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.

Total Volume

$23.9M

Purchases

Sales

$16.2M

Unique Insiders

Price & Insider Trades

ETON daily price over the past year with every insider buy and sale overlaid.

Price data is delayed and provided for context only — not investment advice.

Recent Insider Trades

34 loaded


Aug 4	ETON Eton Pharmaceuticals, Inc.	RIEDEL NORBERT G	Director	Award	$0
Aug 4	ETON Eton Pharmaceuticals, Inc.	Adams Jennifer McKie	Director	Award	$0
Aug 4	ETON Eton Pharmaceuticals, Inc.	MAIER PAUL V	Director	Award	$0
Aug 4	ETON Eton Pharmaceuticals, Inc.	Krempa David	Chief Business Officer	Award	$0
Aug 4	ETON Eton Pharmaceuticals, Inc.	Erdogan-Trinkaus Ipek	Chief Commercial Officer	Award	$0
Aug 12	ETON Eton Pharmaceuticals, Inc.	Radosavljevic Danka	Chief Operating Officer	Other	$0
Aug 4	ETON Eton Pharmaceuticals, Inc.	CASAMENTO CHARLES J	Director	Award	$0
Aug 4	ETON Eton Pharmaceuticals, Inc.	BRYNJELSEN SEAN	President & CEO, Director	Award	$0
Aug 4	ETON Eton Pharmaceuticals, Inc.	Matthews Judith M.	Chief Financial Officer	Award	$0
Jul 16	ETON Eton Pharmaceuticals, Inc.	Opaleye Management Inc.	10% Owner	Sell	$1.1M
Jul 17	ETON Eton Pharmaceuticals, Inc.	Opaleye Management Inc.	10% Owner	Sell	$1.1M
Jul 14	ETON Eton Pharmaceuticals, Inc.	BRYNJELSEN SEAN	President & CEO, Director	Exercise	$548.0K
Jul 13	ETON Eton Pharmaceuticals, Inc.	Krempa David	Chief Business Officer	Exercise	$0
Jul 7	ETON Eton Pharmaceuticals, Inc.	Opaleye Management Inc.	10% Owner	Sell	$4.8M
Jun 30	ETON Eton Pharmaceuticals, Inc.	Krempa David	Chief Business Officer	Award	$0
Jun 17	ETON Eton Pharmaceuticals, Inc.	Adams Jennifer McKie	Director	Sell	$1.6M
Jun 1	ETON Eton Pharmaceuticals, Inc.	Matthews Judith M.	Chief Financial Officer	Other	$0
May 29	ETON Eton Pharmaceuticals, Inc.	BRYNJELSEN SEAN	President & CEO, Director	Sell	$3.8M
May 27	ETON Eton Pharmaceuticals, Inc.	Krempa David	Chief Business Officer	Sell	$3.2M
Apr 22	ETON Eton Pharmaceuticals, Inc.	RIEDEL NORBERT G	Director	Exercise	$521.2K
Feb 5	ETON Eton Pharmaceuticals, Inc.	RIEDEL NORBERT G	Director	Exercise	$265.2K
Jan 14	ETON Eton Pharmaceuticals, Inc.	Erdogan-Trinkaus Ipek	Chief Commercial Officer	Award	$628.9K
Jan 14	ETON Eton Pharmaceuticals, Inc.	RIEDEL NORBERT G	Director	Award	$188.7K
Jan 14	ETON Eton Pharmaceuticals, Inc.	CASAMENTO CHARLES J	Director	Award	$188.7K
Jan 14	ETON Eton Pharmaceuticals, Inc.	Adams Jennifer McKie	Director	Award	$188.7K
Jan 14	ETON Eton Pharmaceuticals, Inc.	MAIER PAUL V	Director	Award	$188.7K
Jan 14	ETON Eton Pharmaceuticals, Inc.	Gruber James R.	Chief Financial Officer	Award	$664.4K
Jan 14	ETON Eton Pharmaceuticals, Inc.	Krempa David	Chief Business Officer	Award	$659.3K
Jan 14	ETON Eton Pharmaceuticals, Inc.	BRYNJELSEN SEAN	President & CEO, Director, 10% Owner	Award	$2.5M
Dec 12	ETON Eton Pharmaceuticals, Inc.	BRYNJELSEN SEAN	President & CEO, Director, 10% Owner	Tax withheld	$113.3K
Dec 12	ETON Eton Pharmaceuticals, Inc.	Erdogan-Trinkaus Ipek	Chief Commercial Officer	Tax withheld	$1.4K
Dec 12	ETON Eton Pharmaceuticals, Inc.	Krempa David	Chief Business Officer	Award	$106.5K
Dec 12	ETON Eton Pharmaceuticals, Inc.	Gruber James R.	Chief Financial Officer	Award	$77.2K
Aug 20	ETON Eton Pharmaceuticals, Inc.	Gruber James R.	Chief Financial Officer	Sell	$673.7K

34 filings